Signature Equity Partners »

Jazz Pharmaceuticals shares owned by Signature Equity Partners

Quarter-by-quarter ownership of Jazz Pharmaceuticals (JAZZ) shares owned by Signature Equity Partners from 13F filings

Historical chart of Signature Equity Partners investment in Jazz Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Jazz Pharmaceuticals held by Signature Equity Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jazz Pharmaceuticals by Signature Equity Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $142k 751 189.05

More positions owned by Signature Equity Partners

Apple (AAPL)
Spdr Gold Tr Gold Shs (GLD)
NVIDIA Corporation (NVDA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Federated Hermes Etf Trust Hermes Total Ret (FTRB)
Boeing Company (BA)
Uwm Holdings Corporation Com Cl A (UWMC)
Ishares Tr Russell 2000 Etf (IWM)
Microsoft Corporation (MSFT)
Amazon (AMZN)
First Tr Exchange-traded Ft Vest S&p 500 (KNG)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Select Sector Spdr Tr State Street Ene (XLE)

View all positions for Signature Equity Partners

Top funds holding Jazz Pharmaceuticals

Vanguard Group
BlackRock
Vanguard Portfolio Management
Capital World Investors
Vanguard Capital Management
LSV Asset Management
Franklin Resources
Dimensional Fund Advisors
State Street Corporation
EcoR1 Capital
Bank of New York Mellon
Hanna Zanoni
Ameriprise Financial
Citadel Advisors
AQR Capital Management

View all funds holding Jazz Pharmaceuticals